Topischer JAK-Inhibitor ist bei NSV anhaltend wirksam und sicher
Crossref DOI link: https://doi.org/10.1007/s15012-024-8623-1
Published Online: 2024-11-20
Published Print: 2024-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gisy, Jenny
Text and Data Mining valid from 2024-11-01
Version of Record valid from 2024-11-01
Article History
First Online: 20 November 2024
Free to read: This content has been made available to all.